Biofrontera Inc. has announced that it is unable to provide an updated financial outlook for 2025 due to current uncertainties. The management team cited a lack of sufficient information to issue a revised forecast at this time. Concerns have been raised regarding Biofrontera Inc.'s ability to fulfill its contractual obligations, which could have material adverse effects on the financial condition of Biofrontera AG, its parent company. Biofrontera Inc. has also expressed doubts about its capital resources, indicating that its future viability depends on executing a growth plan and securing additional financing. The company has acknowledged the potential risk of not being able to raise the necessary capital, which could have significant negative implications for its operations and financial stability. Consequently, the previously communicated forecast for the fiscal year 2025, including EBITDA and revenue growth expectations, can no longer be maintained.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.